关于选择性雌激素受体调节器的更新:重新定位和配方
Riya Patel1, Vanessa James2, Bhupendra Prajapati3,4
1School of Pharmacy, Indrashil University, Rajpur, Kadi, Gujarat, 382715, India.
Naunyn-Schmiedeberg's archives of pharmacology
|January 17, 2025
概括
拉洛西芬化 (RLH),一种SERM,在药物重定位方面表现有前途. 本综述详细介绍了先进的配方策略,专利和分析方法,以优化RLH.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
- 药用化学 医学化学
背景情况:
- 拉洛西芬化物 (RLH),一种选择性雌激素受体调节剂 (SERM),是乳腺癌和骨质疏松症的关键治疗剂.
- 新兴的临床证据表明,RLH在各种病理条件下可能被重新利用.
- 优化RLH的临床实用性需要全面了解其配方,专利格局和分析特征.
研究的目的:
- 提供关于拉洛西芬化 (RLH) 药物重新用途的详细审查.
- 探索RLH的最新配方策略,专利进展和分析方法.
- 确定当前的挑战,并为RLH发展提出未来的研究方向.
主要方法:
- 综合的文献分析,重点是RLH重新定位和分析技术.
- 审查专利数据库,以确定关键的创新和趋势.
- 对配方技术的评估,包括先进的药物输送系统.
主要成果:
- 复杂的分析技术 (光谱,色谱,电化学) 提高RLH测量和质量控制.
- 专利格局显示RLH配方的重大创新,特别是提高溶解性和生物可用性.
- 通过皮肤贴片和纳米颗粒系统等先进的配方技术提供了更好的治疗效果,克服了传统的局限性.
结论:
- 拉洛西芬化 (RLH) 对各种疾病的药物重用具有显著的潜力.
- 在配方和分析技术方面的创新对于最大限度地提高RLH的治疗效益至关重要.
- 对新型药物输送系统的进一步研究和RLH的扩展临床应用是有必要的.
相关概念视频
Internal Receptors
69.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.3K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Dose-Response Relationship: Selectivity and Specificity
6.4K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
Drug-Receptor Interactions
4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


